I
nsulin-dependent diabetes mellitus (IDDM) t is a result of autoimmune destruction of the insulin-producing pancreatic /3 islet cells (for review see reference 1). The/3 islet autoantigenspecific T cells are implicated to play a key role in the pathogenesis of IDDM (2) (3) (4) (5) (6) . Susceptibility to IDDM in humans and in nonobese diabetic (NOD) mice is strongly associated with expression of MHC class II/3 chain that lacks the usual acidic aspartate residue at position 57 (Asp-57) (for review see reference 7). Expression of transgenic class II/3 chain containing the Asp-57 protected the NOD mice from spontaneous development of IDDM (8) (9) (10) (11) (12) . Clonal deletion or functional silencing of/3 islet autoantigen-specific diabetogenic T cells has been proposed as the mechanism whereby these molecules provide protection (4) . However, it is now evident that protection by MHC class II is not mediated by these mechanisms (9, 13, 14) . Since splenic T cells isolated from NOD mice expressing the protective Aa a transgene have the capacity to inhibit adoptive transfer of IDDM, it has been t Abbreviations used in this paper: AMLK, autologous mixed lymphocyte reaction; IDDM, insulin-dependent diabetes mellitus; LPS-blast, LPSactivated splenic blast; MLK, mixed lymphocyte reaction; NOD, nonobese diabetic; SN, supernatant; TCGF, T cell growth factor.
Generation and Maintenance of Autoreactive T Cell Clones. T celt
clones were derived from unprimed 4-wbold female NOD mice purchased from Taconic Farms, Inc. Splenic lymphocytes were cultured in a U-bottomed 96-weLl plate (5 x 10Vwell). T cell clones NOD-2, NOD-5, NOD-6, and NOD-12 were generated in DMEM supplemented with 10% FCS and 4 U/m1 of partially purified rat IL-2 (T cell growth factor [TCGF] , Collaborative Research, Inc., Lexington, MA), whereas clones NOD-14 and NOD-21 were established in FCS-free DMEM supplemented with 0.5% NOD serum and 4 U/m1 recombinant mouse IL-2 (Genzyme Corp., Cambridge, MA) during the first 2 wk of culture. Surviving T ceils were harvested I wk later by Ficoll centrifugation, and they were expanded in flat-bottomed 96-well plate using the same culture medium. I wk later, the surviving T cells were restimulated with NOD spleen cells using the same culture medium but without IL-2 supplementation. After 4 d of selection in ID2-free medium, surviving T ceUs were pooled and were cloned by limiting dilution in culture medium supplemented with 10% FCS and 4 U/ml of rat TCGF and in the presence of freshly isolated irradiated NOD spleen cells (1 x 104 APC/U-bottomed well). T cell clones thus generated were maintained in the T cell medium supplemented with varying concentrations of rat TCGF (4-25 U/ml). They were restimulated with NOD spleen cells at intervals of 2-3 wk.
Proliferation Assays. Proliferation ofT cells was measured as incorporation of [3H] thymidine by the indicated number of T cells for 16-20 h after the specified period of stimulation with irradiated (2,000 tad) APC in the presence or absence of appropriate concentrations of antigens, and in the absence of added IL-2. LPS-activated splenic blast (LPS-blast) APC used for FCS-free activation were prepared from spleen cells depleted of T cells by two rounds of incubation with saturating concentrations of purified mAbs specific for Thy-l.2, CD4, and CD8, followed by complement lysis, all in FCS-free DME. The T cell-depleted spleen cells were cultured for 48 h in FCS-free DME supplemented with 0.5% NOD serum and LPS (10 #g/m1). The resultant blasts were washed twice with PBS before use as APC in a proliferation assay. FCS-free mouse IL-2 was prepared from 24-h culture supernatant of NOD spleen cells stimulated with Con A (5 #g/ml) in RPMI 1640 medium supplemented with only 0.5% NOD serum, and partially purified by NH4SO4 precipitation and extensive dialysis with PBS. Pancreatic ~ islets were isolated from NOD mice according to the method ofBrunstedt et al. (28) using FCS-free DME medium supplemented with 0.5% NOD serum. The islets were digested to single cells in serum-free DME containing trypsin (0.05% wt/vol) and DNase (2 #g/ml) for 30 rain at 37~ with agitation. The islet cells were cultured for 24 h in FCS-free DME/0.5% NOD serum before use.
Assay for Cytokine Production. The Ib2 content of culture supernatants was determined by bioassay using the IL-2-dependent CTLb20 cell line (29) in the presence and absence of anti-Ib2 receptor (PC61 5.3) and anti-IL-4 (11Bll) mAbs (1:10 dilution of hybridoma culture supernatants). 1 U oflb2 is defined as the concentration that supports half-maximal proliferation of CTLL-20 cells. The Ib4, IFN-"/, and TNF-o~ concentrations were determined by ELISA assay. All of the antibodies used in the assays were purchased from PharMingen (San Diego, CA), and the assays were performed according to the manufacturer's protocol. The recombinant IL-4 (Schering-Plough, Kenilworth, NJ), IFN-"/(Amgen Bidogicals, Thousand Oaks, CA), and TNF-ce (Genzyme Corp.) were used as standards for ELISA assays.
AUogeneic Mixed Lymphocyte Reaction (MLR).
The following procedure was routinely performed unless otherwise indicated. 5 x 10 s nylon wool-purified NOD splenic T cells (responders) were cocultured with 5 x 10 s irradiated (2,000 tad) unfractionated spleen cells from DBA/2 mice (stimulators), in the presence or absence of appropriate concentrations of various test reagents, for 116 h. Proliferation of responder T cells was then measured as incorporation of [3H]thymidine during the last 20 h of culture.
Cloning and Sequencing of TCR mRNAs. The TCK ce and chain cDNA molecules were cloned and sequenced by anchored PCR as described previously (30) .
Adoptive Transfer of Diabetes. 8-wk-old male or female NOD mice were irradiated (775 tad). Within 2 h, the mice were injected intravenously with pooled splenocytes (1-2 x 107) derived from newly diabetic female NOD/Lt mice suspended in 400 #1 of sterile PBS. For cotransfer with T cell clones, mice were injected with a mixture of appropriate T cells (1 x 107) and diabetogenic splenocytes (1-2 x 107) suspended together in 400 #1 of PBS. Animals were kept in pathogen-free conditions. Urine was tested for glucose (Keto-Diastix; Miles, Inc., Kankakee, IL), and glycosuric mice were checked for fasting serum glucose (Chemstrip bG, Accu-check III; Boehringer Mannheim Corp., Indianapolis, IN). Diabetes was diagnosed when permanent fasting glyeemia >2.5 g/ liter occurred.
Histology. Recipient mice were killed 21 d after spleen cell transfer. Pancreata were excised, fixed in buffered 10% formalin, and processed for paraffin sectioning. Tissue sections (5 #m) were stained with hematoxylin and eosin and microscopically evaluated for the presence of insulitis by using the following classification: 0, islet devoid of lymphocytic infiltration; 1, inflammatory mononuclear cells located peripheral to the islet; 2, mild insulitis, <25% of the islet interior contains lymphocytic inflammatory cells; 3, moderate insulitis, 25-50% of the interior of the islet contains lymphocytes; 4, severe insulitis, 50-100% of the islet interior is infiltrated; ES, end-stage islets devoid of~ ceUs and associated lymphocytic infiltrate. All islets contained in two noncontiguous sections of the pancreas were examined and scored individually.
Results

Cellular Characteristics of Isolated Autoreactive T Cell Clones.
Our panel of T cell dories was isolated from the spleen of unprimed 4-wk-old female NOD mice by a procedure that selects for growth of T cells reactive to syngeneic APC. The detailed procedure for generation of the clones is described in Materials and Methods. The T cell clones thus established responded routinely to irradiated (2,000 tad) NOD spleen cells in medium containing 10% FCS in the absence of I1-2. Indirect immunofluorescence staining using appropriate mAbs showed that all the clones were Thy-l.2 +, CD4+CD8 -, and TCR-ol/B + (data not shown).
All of the T cell clones (NOD-2, -5, -6, -12, -14, and -21) proliferated vigorously in response to irradiated (2,000 tad) NOD, but not to BALB/C, splenic APC in DME supplemented with 10% FCS (Table 1) . They responded poorly to NOD splenic APC in the FCS-free medium (data not shown). However, NOD-5, -6, -14, and -21 proliferated vigorously in response to stimulation with syngeneic NOD but not to BALB/c LPS-blast APC in FCS-free DME supplemented with only 0.5% NOD serum (Table 1) . In this experiment, the T cell clones were washed twice with FCSflee medium before the assay, and the LPS-blasts were prepared in the absence of FCS and in the presence of 0.5% NOD serum. T cell clones NOD-2 and NOD-12, which we have subsequently determined to be BSA/I-Ag 7 specific, were not activated by syngeneic LPS-blasts ( Table 1) . The I-AgT-cross-reactive mAb 10-2.16, but not the irrelevant MK-D6 mAb (I-A d specific), inhibited the autoreactive responses of T cell clones NOD-5, -6, -14, and -21 (Table 1) . We conclude from data presented in Table 1 that NOD-5, -6, -14, and -21 are I-A~7-restricted autoreactive T cell clones because they can proliferate in response to syngeneic LPSblast APC in the absence of added foreign antigens, and that this response is inhibited by anti-I-As 7 mAb.
T cell clones NOD-2 and NOD-12 are not autoreactive but are BSA/I-Ag 7 specific, because they proliferated in a dose-dependent manner to BSA plus NOD splenic APC, and the responses were inhibited by the anti-I-AgT-cross-reactive 10-2.16 mAb (data not shown). In a similar assay, T cell done, NOD-5, -6, -14, and -21 did not respond to BSA (data not shown). Since the ABBOS BSA peptide sequence (position 152-168) has been implicated as a possible trigger of human IDDM (31), we tested NOD-2 and NOD-12 for reactivity to ABBOS peptide. We observed that neither NOD-2 nor NOD-12 was reactive to ABBOS/I-Ag 7 (data not shown).
The lymphokine production profile of the T cell clones is shown in Table 2 . Upon activation, T cell clones NOD-2, -5, -12, -14, and -21 showed enhancement of I1,2 and IFN-3~ production but not 11,4. The NOD-2, -12, -14, and -21 T cell clones also produced TNF-ol. Cross-reactivity of the antimurine TNF-cz mAb pairs, used in the TNF-ot ELISA assay, with TNF-~ is not known (PharMingen technical information). Clone NOD-6 showed increased production of I1,4 but not of IL-2, IFN-% and TNF-ol. Thus, NOD-6 belongs to the Th2 and the other T cell clones to the Thl subset of T cells (32) .
Specific Self Peptides A re Required for Activation of Autoreactire T Cell Clones. We next asked whether specific self peptides are required for autoreactive responses of NOD-5, -6, -14, and -21. We approached this question by examining the effect ofpeptide Pl on activation of our pand of autoreactive T cell dones. Peptide Pl (.yTYTVHAAHAYTYt; small letters denote D amino acids) has been reported to bind I-As 7 and to block antigen presentation by I-As 7 (27) . We observed that peptide P1 inhibited the autoreactive responses of NOD-5, -6, -14, and -21 T cell dones in a dose-dependent manner ( Fig. 1 ). Peptide Pl also inhibited the BSA-specific responses of NOD-2 and 12 T cell clones, which were included as positive controls (Fig. 1) . The inhibition was specific, since similar concentrations of peptide P2 (KMKMVHAAHAKMKM), which binds I-A a but not I-As 7 (27) , had no effect on the proliferative responses (Fig. 1) . We conclude, therefore, that presentation of specific sdf peptides present on LPS-blasts by I-As7 is required for autoreactive responses of NOD-5, -6, -14, and -21 T cell clones.
Peptide Concentration (pM) Figure 1 . 
Three Autoreactive T Cell Clones Are Reactive to ~ Islet Cell Antigen(s). We tested our panel of autoreactive T cell clones
for reactivity to autoantigens present on NOD pancreatic/~ islet cells. Activation of T cell clones by NOD splenic APC in the presence or absence of NOD islet cells was assessed in FCS-free DME supplemented with 0.5% NOD serum. Fig. 2 shows that NOD-5, -6, -14, and -21 were not significantly activated by NOD splenic APC alone in the FCSfree DME/0.5% NOD serum medium. The addition of 10,000 irradiated (2,000 rad) NOD/~ islet cells to 5 x 10 s NOD splenic APC resulted in enhanced proliferation of NOD-5, -14, and -21 T cell clones. The autoreactive NOD-6 T cell clone, which is similar to NOD-5, -14, and -21 in its responsiveness to LPS-blasts, is not activated by the presence of islet cells.
T Cell Receptor Diversity ofAutoreactive T Cell Clones.
The repertoire of TCRs expressed by the T cell clones was determined. The TCR-c~ and -B cDNAs were amplified by anchored PCR and subcloned into a plasmid vector, and the V/J junctional cDNA sequences were determined. The sequences of the in-frame a and/3 chain V/J junctional CDR-3 region are presented in Fig. 3 , A and B~ The surface V~ expression was confirmed by indirect immunofluorescence using the VB2-, VflS-, and Vfl14-specific mAbs B20.6, F23.1, and 14-2, respectively. Two of the T cell clones express TCR V/~8.1 region (NOD-14 and NOD-21), and two express TCR Vc~4 region (NOD-6 and NOD-14); otherwise, the Vc~, V/~, Jo~, andJB segment usage was diverse, and there was neither apparent sequence identity nor selection for particular amino acid residues in the V/J junctional region. (Fig. 4 A) .
The adoptive transfer procedure is widely accepted as a valid method for rapid assessment of insulitis and diabetes in recipient mice (37). We used this protocol for subsequent testing of T cell clones in vivo. Fig. 4 B shows that all To control for the possibility that BSA-specific T cell clones would not be activated in vivo because of the absence of antigen, we performed an additional experiment whereby the BSA-specific NOD-2 cotransferred mice were given a twicea-week injection of 1 mg BSA per mouse (Fig. 4 B, NOD-2 Expt. 2). Injection of BSA had no effect on the kinetics of development of diabetes.
Protective T Cell Clones Inhibited Lymphocytic Infiltration of Pancreatic Islets. The pancreatic islets of recipient mice, ob-
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V~8.1 tained 3 wk after adoptive transfer, were scored for severity of insulitis according to a standard grading system (see Materials and Methods). Table 3 8-wk-old male and female NOD mice were irradiated (775 red) and received an intravenous injection of 1 x 107 spleen cells pooled from newly diabetic female NOD mice with or without a coinjection of I x 107 of appropriate T cell clones. Mice were killed 3 wk after cell transfers and pancreatic sections were examined and individual islets were graded for degree of insulitis. Grade 0, islet devoid of lymphocytic infiltration; 1, inflammatory mononuclear cells located peripheral to the islet; 2, mild insulitis, <25% of the islet interior contains lymphocytic inflammatory cells; 3, moderate insulitis, 25-50% of the interior of islet contains lymphocytes; 4, severe insulitis, 50-100% of the islet interior is infiltrated; ES, end stage islets devoid of/3 cells and associated lymphocytic infiltrate. * Control T cells are nylon wool-purified splenic T cells derived from 4-wk-old female NOD mice.
APC in 1 ml of DME supplemented with 10% FCS. 48 h later, the activated T cells were separated from dead APC by Ficoll density centrifugation. They were incubated at a density of 1 • 106/ml for another 24 h in DMEM supplemented with 10% FCS without added IL-2. We have determined in a separate time course experiment that our panel ofT cell clones produced Ib2 only during the first 24 h after activation. Thus, SN collected between 48 and 72 h after activation contained an insignificant amount of II.-2. The serially diluted SN were assayed for their ability to inhibit allogeneic MLK. We observed a dose-dependent inhibition of aUogeneic MLR by NOD-5, NOD-14, and NOD-21 SN (Fig. 5) . SN harvested from similarly activated nonprotective autoreactive NOD-6 or BSA-specific NOD-2 and NOD-12 T cell clones were inactive (Fig. 5) . The NOD-5 SN is the most potent of the three SN in inhibiting allo-MLK, followed by NOD-21 SN and then NOD-14 SN. This order of relative potencies of culture supernatants correlated with the protective capacities of the respective T cell clones; that is, NOD-5 is the most protective of the three, followed by NOD-21 and NOD-14. We have examined NOD-5 SN for possible contamination by pathogens that could cause nonspecific growth inhibition. Several batches of active NOD-5 SN have been determined to be free of endotoxin (limulus amebocyte lysate test was performed by Associates of Cape Cod, Inc., Woods Hole, MA), and bacteria (culture supernatant was tested by DanaFarber Cancer Institute hospital microbiology laboratory). We have also verified that NOD-5 T cell clone cultured in antibiotic-free medium for >28 d is free of mycoplasma (mycoplasma test kit, Gibco BRL, Gaithersburg, MD).
Partially Purified Inhibitory Activity Suppressed Adoptive Transfer of IDDM. We next examined the effect of the partially purified allogeneic MLR inhibitory activity, produced by the protective NOD-5 T cell done, on adoptive transfer of IDDM in NOD mice. The Ib2-free SN prepared as described for Fig. 5 were partially purified to (a) concentrate them into a smaller volume suitable for injections, and (b) remove other cytokines, such as TNF, IFN-% TGF-jS, and IL-10. The culture SN were concentrated by precipitation with ammonium sulphate solution (50% saturated). The precipitates were resuspended in one-hundredth of original volumes of PBS and dialyzed extensively against PBS. The dialyzed materials were then passed through heparin-Sepharose column (Pharmacia Biotech, Inc., Piscataway, NJ), which does not bind the NOD-5 inhibitory factor but binds and removes TNF, IFN-% TGF-~, and IL-10 (38-40). The column eluate was the "partially purified SN" used in the adoptive transfer Days after transfer Figure 6 . Partially purified NOD-5 culture supernatant inhibits adopfive transfer of IDDM. 8-wk-old female or male NOD/Lt mice were irradiated (775 rad) 2 h before intravenous injection of 2 x 107 unfractionated pooled spleen cells from newly diabetic female NOD/Lt mice, with or without cotransfer of 300/~1 of partially purified NOD-5 SN or NOD-12 SN. At weekly intervals, the recipient mice received intravenous injection of the same volume of partially purified SN. Animals were kept in pathogen-free condition and were monitored at the indicated intervals for onset of diabetes. experiment described below. We have verified that the 100-fold concentrated and partially purified SN was '~50-fold more potent than the starting material in inhibiting aUogeneic MLR (data not shown).
The partially purified NOD-5 or NOD-12 SN (300 #1 each), which is equivalent to a starting volume of 3 ml culture SN, was coinjected with 2 x 107 donor diabetogenic spleen cells intravenously into preirradiated (775 tad) recipient NOD mice. At weekly intervals, the mice received intravenous injections of the same volume of partially purified SN. In two separate experiments, we observed that injection of the partially purified NOD-5 SN but not NOD-12 SN significantly protected NOD mice from adoptive transfer of IDDM (Fig. 6) . The degree of protection was not as impressive as cotransfer of NOD-5 T cell clones as shown in Fig.  4 B, suggesting that component(s) other than the secreted inhibitory factor may play additional roles in the protective action of NOD-5. Alternatively, the dose and frequency of injection of the partially purified NOD-5 SN may not have been optimal for protection.
Discussion
Our study was initiated by the hypothesis that autologous MLR (AMLR), or syngeneic MLR, which is present in all normal individuals, may represent interactions among T lymphocytes and other immunological cells that regulate immune responses in the absence of foreign antigens. The frequent association of impaired AMLR with autoimmune diseases in humans (reviewed in 41) and in mice (42) further supports the hypothesis that "'AMLR-competent" T cells may Flay a role in maintaining peripheral T cell tolerance to self antigens. With this hypothesis in mind, we attempted to isolate "AMLR-competent" T cell clones, which we defined initially as T cell clones that are capable of responding to syngeneic APC in the absence of added foreign antigens. We chose to do this isolation in a relevant autoimmune animal model (NOD mouse) that manifested deficient AMLR (43. 44) .
We have succeeded in isolating four "AMLR-competent" T cell clones from the spleens of unprimed NOD mice. These T cell clones can be activated by stimulation with (a) NOD splenic APC in the presence of 10% FCS; (b) NOD LPSstimulated splenic blasts in the absence of FCS; and (c) NOD splenic APC plus ~/islet cells in the absence of FCS for three of the clones. We postulate that LPS-activated B cells and macrophages express high levels of self antigens, which are required for recognition by autoreactive T cell clones. FCS may be required because it contains factors that activate these APC, a possibility that has been discussed by Clayberger et al. (45) . We have narrowed antigen specificity of clones NOD-5, -14, and -21 to self antigens expressed on NOD ~/islet cells. The islet antigen(s) recognized by these T cell clones are likely to be expressed on LPS-blasts and FCSstimulated APC as well, since these APC are capable of activating the T cell clones in the absence of islet cells.
The autoreactive T cell clones NOD-5, -6, -14, and -21 express TCR bearing V~/14, VB2, V~8.1, and V~8.1 regions, respectively. There was no predominant selection for use of any particular Vo~ or V~ segment by our panel of autoreac-tive T cell clones, indicating that I-Ag 7 restriction is not associated with preferential usage of a particular V region segment. There was no apparent selection for specific amino acid residues within the V/J junctional region. The presence of selective junctional amino acid usage would have implications for a restricted self peptide specificity (46) . The lack of restricted V region TC1K sequences suggests the TCR may recognize either a diverse set of target antigens or different epitopes of a single target antigen. We need to know the selfpeptides recognized by our panel of TCR to discriminate between these two possibilities.
We have shown that the 13 islet cell-reactive NOD-5, NOD-14, and NOD-21 T cell clones significantly inhibited adoptive transfer of IDDM. The protective capacity of these Thl T cell clones is not correlated with production of II,-2, TNF, or IFN-3'. These cytokines are also produced by the BSA-specific NOD-2 and NOD-12 T cell clones, which were not protective even when BSA was coadministered to the recipient mice. Depending on the age and route of administration, TNF-a and IFN-y have been reported to exacerbate or inhibit IDDM development in NOD mice (47) (48) (49) (50) . Our panel of Thl T cell clones does not exacerbate disease and the BSA-spedfic Thl T cell clones do not inhibit disease. These phenomena suggest that the in vivo level of TNF-o~ and IFN-3' produced by the inoculated T cell clones may be inadequate to affect disease development. The level of TNF-ot and IFN-y production may be limited by the concentrations of the activating autoantigens available in vivo. ILo2, IFN-3', and TNF-o~ lymphokines are produced by our panel of Thl T cell clones only during the first 24 h after activation. In contrast, production of the allo-MLR inhibitory factor by the protective T cell clones persisted for 3 wk after activation (Akhtar, I., and K.-N. Tan, manuscript in preparation). Therefore, the in vivo effect of the protective Thl T cell clones is likely to be dominated by the allo-MLR inhibitory factor.
We have shown that protective capacity of these T cell dones correlates with (a) their reactivity to/3 islet cell antigen(s), and (b) their production of an activity that potently suppresses allogeneic MLIK in vitro. The/3 islet cell reactivity may dictate the specificity of action of the protective T cell clones. We observed that protective T cell clones inhibited intraislet but not periislet lymphocytic infiltration. It is possible that the protective islet-reactive T cell clones may migrate to and reside near the islets, thereby inhibiting intraislet lymphocytic infiltration of diabetogenic lymphocytes. This possibility remains to be verified. With regard to production of a factor that inhibits allogeneic MLR, our panel of protective autoreactive T cell clones resembles the contemporary definition of suppressor T cells, in that they produce factor(s) capable of down-regulating immune responses. The partially purified inhibitory activity secreted by NOD-5, which was first depleted of IL-2, IFN-3', TNF, TGF-13, and IL-10, retained its ability to protect mice from adoptive transfer of IDDM. The biological and biochemical characteristics of this activity will be reported elsewhere (Akhtar, I., and K.-N. Tan, manuscript in preparation). Identification of the molecular structure of this factor, presently in progress, should allow us to further delineate the mechanism of action of this molecule.
The reason for development of our panel of protective T cell clones into a Thl lineage is at present unclear. Autoimmunity is usually attributed to Thl cells, whereas Th2 responses are regarded as protective (51) . Furthermore, recent observations indicate that susceptibility or resistance to spontaneous autoimmunity in different strains of mice is influenced by a non-MHC-encoded polymorphism that dictates predisposition of T cells toward preferential differentiation to Thl versus Th2 phenotype, with Th2 being protective and Thl pathogenic (52) . Our panel of protective autoreactive T cell clones is Thl instead of Th2 and therefore appears to contradict these expectations. However, there are other reports that disagree with the simple prediction that Thl is pathogenic and Th2 is protective. For example, Wogensen et al. have shown that transgenic expression of IL-10 in/3 islet cells, which promoted a Th2-1ike lymphokine pattern of isletinfiltrating cells, accelerated the onset of diabetes and increased its prevalence. The authors suggested that 13 cell destruction in NOD mice may therefore sometimes be a Th2-mediated event (53) . Additionally, recent observations indicate that the inflammatory loci in NOD mice are dominated by a Th2 cytokine response (54) . It is likely that/3 cell destruction and T cell suppression of autoimmunity may each involve a more complex interplay between Thl and Th2 cells than is currently conceived. The respective roles of these subsets may vary depending on the stage of the disease and on the site of action. Our data provide clear evidence in support of the existence of Thl/3 islet cell-reactive T cells that have acquired a protective effector function. They mediate their protective action in part by production of an activity capable of downmodulating immune responses. We suggest that this type of CD4 + autoreactive T cells may form part of a regulatory network of T cells that normally plays a role in maintaining peripheral tolerance.
